Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice

Journal of Nutritional Biochemistry

Volumn 24, Issue 3, 2013, Pages 567-577

  Karavia, Eleni A ^a   Papachristou, Dionysios J ^a   Kotsikogianni, Ioanna ^a   Triantafyllidou, Irene Eva ^a   Kypreos, Kyriakos E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Apolipoproteins; Cholesteryl ester; Fatty liver; Lecithin cholesterol acyltransferase deficiency; Lipoproteins; Steatosis

Indexed keywords

ADENOVIRUS VECTOR; CARBOHYDRATE; CHOLESTEROL; FAT; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; FAT INTAKE; FOOD INTAKE; HISTOPATHOLOGY; IN VITRO GENE TRANSFER; INTESTINE ABSORPTION; LIPID ABSORPTION; LIPID STORAGE; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PROTEIN FUNCTION; PROTEIN INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; BODY WEIGHT; DIET; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LECITHIN ACYLTRANSFERASE DEFICIENCY; LIPOPROTEINS, VLDL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PLANT OILS; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

ADENOVIRIDAE; MUS;

EID: 84875503214     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.02.007     Document Type: Article

References (32)

1. Simon J.B., Boyer J.L. Production of lecithin/cholesterol acyltransferase by the isolated perfused rat liver. Biochim Biophys Acta 1970, 218:549-551.
2. Osuga T., Portman O.W. Origin and disappearance of plasma lecithin:cholesterol acyltransferase. Am J Physiol 1971, 220:735-741.
3. Soutar A.K., Garner C.W., Baker H.N., Sparrow J.T., Jackson R.L., Gotto A.M., et al. Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin:cholesterol acyltransferase. Biochemistry 1975, 14:3057-3064.
4. Santamarina-Fojo S., Hoeg J.M., Assmann G., Brewer H.B. The Metabolic & Molecular Bases of Inherited Disease 2001, 2817-2834. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
5. Norum K.R., Gjone E. Familial serum-cholesterol esterification failure. A new inborn error of metabolism. Biochim Biophys Acta 1967, 144:698-700.
6. Norum K.R., Gjone E. The effect of plasma transfusion on the plasma cholesterol esters in patients with familial plasma lecithin:cholesterol acyltransferase deficiency. Scand J Clin Lab Invest 1968, 22:339-342.
7. Gjone E., Norum K.R. Familial plasma cholesterol ester deficiency. A new inborn error of metabolism. Nord Med 1968, 80:878-883.
8. Torsvik H., Gjone E., Norum K.R. Familial plasma cholesterol ester deficiency. Clinical studies of a family. Acta Med Scand 1968, 183:387-391.
9. Gjone E., Norum K.R. Familial serum cholesterol ester deficiency. Clinical study of a patient with a new syndrome. Acta Med Scand 1968, 183:107-112.
10. Hamnstrom B., Gjone E., Norum K.R. Familial plasma lecithin:cholesterol acyltransferase deficiency. Br Med J 1969, 2:283-286.
11. Norum K.R., Borsting S., Grundt I. Familial lecithin:cholesterol acyltransferase deficiency. Study of two new patients and their close relatives. Acta Med Scand 1970, 188:323-326.
12. Glomset J.A., Norum K.R., King W. Plasma lipoproteins in familial lecithin:cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro. J Clin Invest 1970, 49:1827-1837.
13. Schaefer E.J., Santos R.D., Asztalos B.F. Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol 2010, 21:289-297.
14. Forte T., Norum K.R., Glomset J.A., Nichols A.V. Plasma lipoproteins in familial lecithin:cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by elctron microscopy. J Clin Invest 1971, 50:1141-1148.
15. Kypreos K.E., Zannis V.I. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Biochem J 2007, 403:359-367.
16. Brousseau M.E., Kauffman R.D., Herderick E.E., Demosky S.J., Evans W., Marcovina S., et al. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits. Arterioscler Thromb Vasc Biol 2000, 20:450-458.
17. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004, 114:147-152.
18. Byrne C.D., Olufadi R., Bruce K.D., Cagampang F.R., Ahmed M.H. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 2009, 116:539-564.
19. Cortes V.A., Curtis D.E., Sukumaran S., Shao X., Parameswara V., Rashid S., et al. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab 2009, 9:165-176.
20. Tirosh O., Artan A., Aharoni-Simon M., Ramadori G., Madar Z. Impaired liver glucose production in a murine model of steatosis and endotoxemia: protection by inducible nitric oxide synthase. Antioxid Redox Signal 2010, 13:13-26.
21. Sakai N., Vaisman B.L., Koch C.A., Hoyt R.F., Meyn S.M., Talley G.D., et al. Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency. J Biol Chem 1997, 272:7506-7510.
22. Kypreos K.E. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia. Biochemistry 2008, 47:10491-10502.
23. Kypreos K.E., Teusink B., Van Dijk K.W., Havekes L.M., Zannis V.I. Analysis of the structure and function relationship of the human apolipoprotein E in vivo, using adenovirus-mediated gene transfer. FASEB J 2001, 15:1598-1600.
24. Papachristou D.J., Papadakou E., Basdra E.K., Baltopoulos P., Panagiotopoulos E., Papavassiliou A.G. Involvement of the p38 MAPK-NF-kappaB signal transduction pathway and COX-2 in the pathobiology of meniscus degeneration in humans. Mol Med 2008, 14:160-166.
25. Karagiannides I., Abdou R., Tzortzopoulou A., Voshol P.J., Kypreos K.E. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. FEBS J 2008.
26. Duivenvoorden I., Teusink B., Rensen P.C., Romijn J.A., Havekes L.M., Voshol P.J. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice. Diabetes 2005, 54:664-671.
27. Kypreos K.E., Van Dijk K.W., van Der Z.A., Havekes L.M., Zannis V.I. Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion. J Biol Chem 2001, 276:19778-19786.
28. Kypreos K.E., Van Dijk K.W., Havekes L.M., Zannis V.I. Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia. J Biol Chem 2005, 280:6276-6284.
29. Schotz M.C., Scanu A., Page I.H. Effect of triton on lipoprotein lipase of rat plasma. Am J Physiol 1957, 188:399-402.
30. Song H., Zhu L., Picardo C.M., Maguire G., Leung V., Connelly P.W., et al. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism. Am J Physiol Endocrinol Metab 2006, 290:E17-E25.
31. Li L., Hossain M.A., Sadat S., Hager L., Liu L., Tam L., et al. Lecithin cholesterol acyltransferase null mice are protected from diet-induced obesity and insulin resistance in a gender-specific manner through multiple pathways. J Biol Chem 2011, 286:17809-17820.
32. Sabesin S.M., Hawkins H.L., Kuiken L., Ragland J.B. Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease. Gastroenterology 1977, 72:510-518.